Salica

Salica is a London-based global venture capital firm that backs high-growth technology companies, with healthcare exposure concentrated in health IT, healthcare software, and digital health. The firm is not an AI-specialist investor, though software-driven business models naturally fit the thesis. Salica positions itself as an active co-investor, often working alongside other institutional backers to scale established UK and Irish startups rather than leading entirely on its own. Founders working in patient-facing applications, clinician workflow software, or data-rich health platforms are the natural fit for the team.

The firm focuses on Series A and Series B rounds, deploying checks in the $1M to $5M range from its London headquarters. Geographic priority sits firmly with the United Kingdom and Ireland, where Salica has built its co-investing network and operating relationships, though the broader mandate reaches across Europe. Companies that have moved beyond product-market fit and are looking for growth capital to expand commercially are best positioned to engage. The check size suggests Salica typically takes a meaningful minority position rather than acting as a small follow-on participant.

The partner roster and named portfolio companies are not detailed in the materials reviewed here, so limited public information is available on the team’s specific backgrounds or representative investments. Founders considering Salica should expect a co-investor mindset rather than a lead-everything posture, and should come prepared with a clear syndicate plan. Direct outreach with a tight commercial summary, traction metrics, and an explanation of how UK or Irish market presence factors into the company’s growth path is the most efficient way to start a conversation.